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Myocardial Reperfusion with Streptokinase in an Asian Population
with Acute Myocardial Infarction: Analysis of 60-Minute ST
Resolution
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From Department of Medicine, Ruttonjee Hospital1 and Queen Mary Hospital2, Hong Kong; Cardiologia, Centro
Hospitalar Conde de São Januário3, Macau, China
CHEN ET AL .: Myocardial Reperfusion with Streptokinase in an Asian Population with Acute Myocardial
Infarction: Analysis of 60-Minute ST Resolution. Aims: We sought to determine the efficacy of streptokinase in
myocardial reperfusion in an Asian population with acute myocardial infarction by using 60-minute ST resolution
and the predictors of complete ST resolution. Materials and Methods: We conducted a retrospective study on 96
consecutive Asian patients with acute myocardial infarction. All received streptokinase and had interpretable
electrocardiograms (ECGs) before and 60 minutes after streptokinase initiation. ST resolution was categorised into
three groups: complete (≥70%), partial (30% to <70%) and no (0% to <30%). Independent predictors of complete
resolution were identified by multivariate analysis. The incidence of complete, partial, and no ST resolution was
24%, 27%, and 49% respectively. Independent predictors of complete ST resolution were inferior infarction (OR
7.82; CI 2.58-23.68; p=0.0003) and smoking history (OR 5.2; CI 1.42-19.07; p=0.0147). In a subgroup of patients
(n=43) with interpretable ECGs at both 60 and 90 minutes, the incidence of complete, partial and no ST resolution
changed from 12%, 23%, and 65% to 26%, 44%, and 30% respectively (p=0.01). Conclusion: Streptokinase restored
myocardial perfusion in 24% of an Asian population 60 minutes after initiation. Independent predictors of myocardial
reperfusion were inferior infarction and smoking history. The majority of patients without complete ST resolution at
60 minutes did not have successful myocardial reperfusion by 90 minutes without additional intervention. (J HK Coll
Cardiol 2001;9:133-138)
Acute myocardial infarction, Asians, fibrinolysis, myocardial reperfusion, ST resolution, streptokinase

≥

Address for reprints: Prof. Chu-Pak Lau
Division of Cardiology, Department of Medicine, The University
of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong
Tel: (852) 2855 4244, Fax: (852) 2855 1143
Received April 2, 2001; revision accepted June 13, 2001

J HK Coll Cardiol, Vol 9

July 2001

133

MYOCARDIAL REPERFUSION, STREPTOKINASE, MYOCARDIAL INFARCTION

Introduction

Materials and Methods

Reperfusion therapy using fibrinolytic agents is
the standard of care in the management of patients
presenting with ST-elevation myocardial infarction. The
goal of reperfusion therapy is rapid, complete, and
sustained restoration of normal flow in the infarct-related
artery (IRA), thereby preserving left ventricular function
and reducing mortality. Recent evidence has shown that
re-establishment of normal epicardial flow does not
mean successful myocardial reperfusion. 1 Despite
attaining Thrombolysis in Myocardial Infarction grade
3 flow in the IRA, myocardial reperfusion may still be
impaired after primary percutaneous transluminal
coronary angioplasty. This is associated with larger
infarcts, poor left ventricular functional recovery, and
increased mortality. 2-6 Two methods have been
developed recently to characterise myocardial
reperfusion. The Thrombolysis in Myocardial Infarction
myocardial perfusion grade uses the clearance of the
myocardial blush on the coronary angiogram to define
different grades of myocardial reperfusion. 7 This
angiographic method of assessing myocardial
reperfusion involves the performance of an invasive
procedure and is not readily available. Resolution of ST
elevation on the surface electrocardiogam (ECG) has
been shown to correlate closely with myocardial contrast
echocardiography findings 8 and thus is a marker of
myocardial reperfusion. Moreover, ST resolution carries
prognostic implications in patients with acute
myocardial infarction receiving fibrinolytic agents or
undergoing primary percutaneous transluminal coronary
angioplasty.9-15
Although new fibrinolytic agents have been
developed and are starting to replace tissue plasminogen
activator in the Western population, streptokinase is still
used in many parts of the world as the fibrinolytic of
first choice in ST-elevation myocardial infarction.
Large-scale randomised controlled trials on the efficacy
and safety of fibrinolytic therapy in acute myocardial
infarction have not been performed on the Asian
population. We sought to determine the efficacy of
streptokinase, which is more frequently used than tissue
plasminogen activator in Asia, in restoring myocardial
perfusion in an Asian population with acute myocardial
infarction. We assessed myocardial reperfusion by
analysing 60-minute ST resolution, and sought to
identify the predictors of complete ST resolution.
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Study Population
We conducted a retrospective study on
consecutive Asian patients admitted to the 3
participating institutions (Ruttonjee Hospital, Queen
Mary Hospital, and Centro Hospitalar Conde de São
Januário) from July 1999 to June 2000 with a diagnosis
of acute myocardial infarction. All hospitals are major
regional hospitals with an Emergency Department
serving a predominant Asian population (>95%). Acute
myocardial infarction was diagnosed by ischaemic chest
discomfort ≥30 minutes in duration and ST segment
elevation ≥0.1 mV in two contiguous limb leads or
≥0.2 mV in two contiguous precordial leads. We limited
the analysis to cases in which 1.5 million units of
streptokinase were given and 12-lead ECGs before and
60 minutes after the administration of streptokinase were
available.

ECG Analysis
ECGs of patients from each institution were
analysed by a single investigator of that institution
(WHC, PYL & TMM). The method of ECG analysis
reported by Schröder et al was used.16 The magnitude
of ST segment elevation was measured manually 20
ms after the end of the QRS complex from leads I, aVL
and V1 to V6 for anterior MI and leads II, III, aVF and
V5 to V6 for inferior MI. Reciprocal ST depression
≥0.1 mV in leads II, III and aVF for anterior MI and in
leads V1 to V4 for inferior MI were included. The sum
of ST deviation was calculated at baseline and 60
minutes after initiation of streptokinase. Whenever
available, measurement was also made at 90 minutes.
The percent resolution of ST deviation was calculated
and categorised into 3 groups according to Schröder's
definition: complete resolution (≥70%), partial
resolution (30% to <70%), and no resolution (0% to
<30%).

Statistical Analysis
Continuous variables were expressed as mean±SD
and 95% confidence interval where appropriate.
Categorical variables were compared using Pearson chi
square tests or Fisher's exact test where appropriate.
Continuous variables were compared using one-way
analysis of variance (ANOVA) (F tests). A logistic
regression analysis using forward technique was
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employed to determine significant independent
predictors of complete ST resolution. A significant level
was defined when p<0.05. Data were analysed using
the SPSS 6 software package (SPSS Inc., Prentice Hall,
New Jersey).

Results
The clinical characteristics of the patients are
summarized in the Table 1. Among the 96 patients with
interpretable ECGs 60 minutes after initiation of
streptokinase, 24%, 27%, and 49% had complete, partial,
and no ST resolution respectively. When compared with
the groups with partial or no resolution, the group with
complete resolution had a higher prevalence of a
smoking history (p=0.027) and an inferior location of
myocardial infarction (p=0.0001). More patients with

complete resolution (91%; versus 62% and 68% for the
partial and no resolution groups respectively; p<0.05)
received streptokinase ≤4 hours after symptom onset.
The mean symptom-onset to treatment time was 80
minutes earlier for the complete resolution group
compared with the other two groups combined (160±71
minutes versus 240±189 minutes; p=0.003). Almost
80% of the patients with complete resolution had inferior
infarction. The reverse was noted in the partial resolution
group. More anterior myocardial infarction was also
observed among patients with no resolution but of a
smaller magnitude (~60%). For patients with inferior
myocardial infarction, 83% had a symptom-onset to
treatment time ≤240 minutes and 59% had a sum of ST
deviation ≤1.0 mV, compared with 64% and 33%
respectively of patients with anterior myocardial
infarction. Prior myocardial infarction was less common
in the complete resolution group than in the partial

Table 1. Clinical characteristics of patients classified according to ST resolution at 60 minutes after
administration of streptokinase. Σ ST ∆ = sum of ST deviation before streptokinase infusion
All
Mean age (y)
>65, %
Chinese, %
Male sex, %
Diabetes, %
Hypertension, %
Hypercholesterolaemia, %
Current or ex-smoker, %
Prior MI, %
Heart failure, %
Anterior MI, %
Killip class >1, %
Cardiogenic shock, %
Mean duration from
symptom-onset to
treatment, min
Time from symptom onset
to treatment ≤240 min, %
Σ ST ∆, mV
- Anterior MI
- Inferior MI
In-hospital mortality, %
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Partial resolution
[n=26 (27%)]
65
50
92
81
31
38
54
54
27
4
81
27
12
247

No Resolution
[n=47 (49%)]
66
55
94
79
17
36
55
57
6
4
62
30
6
237

p value

65
53
95
82
22
36
58
65
11
3
58
23
7
241

Complete Resolution
[n=23 (24%)]
64
52
100
91
22
35
70
87
4
0
22
13
4
160

72

91

62

68

0.0497

1.5±1.0
1.8±1.1
1.1±0.7
10

1.2±0.9
2.1±1.0
1.0±0.7
0

1.7±1.2
1.8±1.3
1.3±0.1
19

1.5±0.9
1.8±1.0
1.1±0.6
17

NS
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NS
NS
NS
NS
NS
NS
NS
0.027
0.014
NS
0.0001
NS
NS
NS

NS
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resolution group, but was of similar prevalence to the
no resolution group. A trend of lower in-hospital
mortality was observed among patients with complete
resolution (p=0.089).
Variables associated with complete resolution by
univariate analysis were inferior infarction (p=0.00008),
smoking history (p=0.007), symptom-onset to treatment
time ≤4 hours (p=0.017), and absence of acute
congestive heart failure (p=0.049). By multivariate
analysis, inferior MI (odds ratio 7.8, 95% confidence
interval 2.59-23.68; p=0.0003) and smoking history
(odds ratio 5.2, 95% confidence interval 1.42-19.07;
p=0.0147) were independent predictors of complete
resolution.
For a subgroup of patients (n=43) with interpretable ECGs 60 and 90 minutes after commencement
of streptokinase, the incidence of complete resolution
increased from 12% at 60 minutes to 26% at 90 minutes
(p=0.01145). The incidence of partial resolution also
increased from 23% to 44%. Conversely, during the
same time interval the incidence of no resolution
decreased from 65% to 30%. (Figure 1)

Discussion
To our knowledge this is the first analysis on
myocardial reperfusion measured by ST resolution at
60 minutes in an Asian population treated with
streptokinase for acute myocardial infarction. The ISAM
and INJECT substudies reported on ST resolution at 180
minutes after streptokinase in Caucasian patients.9,16
Complete ST resolution occurred in about half the
patients 180 minutes after streptokinase initiation.
Compared with these two studies and recent trials on
reperfusion therapy in acute myocardial infarction,15,17-18
our population was older, had more diabetes, anterior
myocardial infarction, and higher Killip classes. These
characteristics are more typical of patients treated in
the community rather than those selected for reperfusion
trials. Streptokinase was able to restore myocardial
perfusion in about a quarter of this high-risk cohort with
acute myocardial infarction within 60 minutes of
therapy. The unfavourable profile of our population may
partly account for the large difference in complete ST
resolution measured at an earlier time frame. Our data

(% patients)
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40
30
20
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12
26
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44
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30

No

23

65

STR 60

STR 90

Figure 1. Distribution of ST resolution of 43 patients at 60 and 90 minutes after administration of
streptokinase. STR 60=ST resolution at 60 minutes. STR 90=ST resolution at 90 minutes.
136

July 2001

J HK Coll Cardiol, Vol 9

CHEN ET AL.

also suggested that streptokinase is inferior to
lanoteplase, a third-generation fibrinolytic, in
accomplishing early myocardial reperfusion. ST
resolution at 60 minutes was achieved in 33% of the
patients treated with lanoteplase,19 compared with 24%
in our study.
Smoking history (including both current and exsmokers) and inferior myocardial infarction were
identified as independent predictors of successful
myocardial reperfusion. These two variables have also
been reported as determinants of a lower short-term
mortality among patients treated with fibrinolytic
therapy in the GUSTO-I trial.20 It has been suggested
that smokers have a smaller atherosclerotic burden and
a higher thrombus load at the site of coronary occlusion,
and therefore respond better to fibrinolytic therapy.21
However, subsequent angiographic studies did not
confirm this hypothesis. Grines et al22 found that smokers
had a larger minimum luminal diameter of the IRA
stenosis but a similar percent diameter stenosis whereas
Zahger et al.23 observed no differences with respect to
residual stenosis and thrombus grade between smokers
and non-smokers. One finding in common is the higher
incidence of Thrombolysis in Myocardial Infarction
grade 3 flow at 90 minutes, which is the most important
factor to account for the short-term survival benefit of
smokers. Purcell et al, using the ST resolution in the
lead with maximum ST elevation, showed a similar
incidence of 50% resolution at 60 minutes between
current smokers and non-smokers (44% vs 43%). More
non-smokers compared with current smokers failed to
achieve a 25% ST resolution by 180 minutes (35% vs
16%).24 Our findings confirm the better response of
patients with a smoking history to fibrinolytic therapy
and provide additional insight by showing enhanced
early myocardial reperfusion in these patients. By
mechanisms still unknown, the favourable response to
fibrinolysis in current and ex-smokers is seen in the
better myocardial reperfusion and is translated into a
short-term survival benefit.
We observed in the present study that fewer
patients with anterior myocardial infarction achieved
complete resolution, a finding consistent with the results
of other studies.9,16,25-28 This may be explained by the
systematic under-estimation of the degree of ST
resolution in patients with anterior myocardial infarction
because the J point is not uncommonly elevated in the
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anterior precordial leads in normal and pathological
states. 25 Another explanation may be that anterior
myocardial infarction is associated with a higher
resistance to myocardial reperfusion. A large area of
myocardium at risk is present in anterior myocardial
infarction. Moreover, more patients with anterior
myocardial infarction in the present study had an
ischaemic time longer than 4 hours compared with
patients with inferior myocardial infarction (36% vs
17%, p=0.037). Both factors are related to oxidative
stress and a lack of recovery of aerobic metabolism.
Subsequent neutrophil plugging of capillaries and
oedema lead to an increased impedance to flow.11,19
These factors may account for the poor response of
anterior myocardial infarction to fibrinolytic therapy for
myocardial reperfusion compared with inferior
myocardial infarction.
The prognostic value of 60-minute ST resolution
has been validated in the InTIME-II substudy. A
stepwise correlation exists between 60-minute ST
resolution and both the short- and long-term mortality.19
In the present study, we also noted a trend for lower inhospital mortality among patients with complete
resolution. Although a proportion of patients developed
complete resolution without further treatment from 60
to 90 minutes, approximately three-quarters of the
patients still did not achieve complete resolution by 90
minutes after initiation of streptokinase. By analysing
the ECG 60 minutes after fibrinolytic therapy, a simple,
quick, and non-invasive method is available to guide
decision on further management. For patients without
complete ST resolution by 60 minutes, a large proportion
(84%) will continue to have partial or no resolution by
90 minutes. These patients either have the infarct-related
artery persistently occluded, or no myocardial salvage
despite a patent infarct-related artery by angiography.8,25
Given the promising results of rescue percutaneous
transluminal coronary angioplasty, this group of patients
should be considered for emergency revascularisation.
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